117 related articles for article (PubMed ID: 37943840)
1. Construction of truncated PSMA as a PET reporter gene for CAR T cell trafficking.
Zhang Y; Song X; Xu Z; Lv X; Long Y; Lan X; Lei P
J Leukoc Biol; 2024 Feb; 115(3):476-482. PubMed ID: 37943840
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive longitudinal PET/CT imaging of CAR T cells using PSMA reporter gene.
Song X; Zhang Y; Lv X; Xu Z; Long Y; Gai Y; Jiang D; Lei P; Lan X
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):965-977. PubMed ID: 37971500
[TBL] [Abstract][Full Text] [Related]
3. Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.
Alvim R; Nagar K; Das S; Lebdai S; Wong N; Somma A; Hughes C; Thomas J; Monette S; Scherz A; Kim K; Grimm J; Coleman JA
Eur Urol Focus; 2021 Mar; 7(2):472-478. PubMed ID: 31227464
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
Singh B; Sharma S; Bansal P; Hooda M; Singh H; Parihar AS; Kumar A; Watts A; Mohan R; Singh SK
Nucl Med Commun; 2021 May; 42(5):482-489. PubMed ID: 33395191
[TBL] [Abstract][Full Text] [Related]
5. How accurate is
Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
[TBL] [Abstract][Full Text] [Related]
6. Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene.
Sellmyer MA; Richman SA; Lohith K; Hou C; Weng CC; Mach RH; O'Connor RS; Milone MC; Farwell MD
Mol Ther; 2020 Jan; 28(1):42-51. PubMed ID: 31668558
[TBL] [Abstract][Full Text] [Related]
7. Primary lymph-node staging with
Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
[TBL] [Abstract][Full Text] [Related]
8. Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer.
Hassani M; Hajari Taheri F; Sharifzadeh Z; Arashkia A; Hadjati J; van Weerden WM; Modarressi MH; Abolhassani M
J Cell Biochem; 2019 Jun; 120(6):10787-10795. PubMed ID: 30672018
[TBL] [Abstract][Full Text] [Related]
9. Monitoring the efficacy of adoptively transferred prostate cancer-targeted human T lymphocytes with PET and bioluminescence imaging.
Dobrenkov K; Olszewska M; Likar Y; Shenker L; Gunset G; Cai S; Pillarsetty N; Hricak H; Sadelain M; Ponomarev V
J Nucl Med; 2008 Jul; 49(7):1162-70. PubMed ID: 18552144
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer.
Barbosa ÁRG; Amaral BS; Lourenço DB; Bianco B; Gushiken FA; Apezzato M; Silva JF; Cunha MLD; Filippi RZ; Baroni RH; Lemos GC; Carneiro A
Einstein (Sao Paulo); 2022; 20():eAO6599. PubMed ID: 35584444
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. A Fluorescent, [
Guo H; Kommidi H; Vedvyas Y; McCloskey JE; Zhang W; Chen N; Nurili F; Wu AP; Sayman HB; Akin O; Rodriguez EA; Aras O; Jin MM; Ting R
ACS Chem Biol; 2019 Jul; 14(7):1449-1459. PubMed ID: 31120734
[TBL] [Abstract][Full Text] [Related]
13. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
Fendler WP; Calais J; Eiber M; Flavell RR; Mishoe A; Feng FY; Nguyen HG; Reiter RE; Rettig MB; Okamoto S; Emmett L; Zacho HD; Ilhan H; Wetter A; Rischpler C; Schoder H; Burger IA; Gartmann J; Smith R; Small EJ; Slavik R; Carroll PR; Herrmann K; Czernin J; Hope TA
JAMA Oncol; 2019 Jun; 5(6):856-863. PubMed ID: 30920593
[TBL] [Abstract][Full Text] [Related]
14. (R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.
Gourni E; Canovas C; Goncalves V; Denat F; Meyer PT; Maecke HR
PLoS One; 2015; 10(12):e0145755. PubMed ID: 26700033
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceutical for detecting PSMA - positive metastatic colon cancer: Matched-pair comparison of 18F-BF3-Cy3-ACUPA and 68Ga-PSMA PET/MRI.
Aras O; Demirdag C; Kommidi H; Ting R; Sayman HB
Nucl Med Rev Cent East Eur; 2022; 25(2):129-130. PubMed ID: 35699591
[TBL] [Abstract][Full Text] [Related]
16. Is there a nonnegligible effect of maximum standardized uptake value in the staging and management of prostate cancer with 68Ga-prostate-specific membrane antigen positron emission tomography/computerized tomography imaging? A single-center experience.
Ekmekcioglu O; Yavuzsan AH; Arican P; Kirecci SL
J Cancer Res Ther; 2021; 17(6):1351-1357. PubMed ID: 34916365
[TBL] [Abstract][Full Text] [Related]
17. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
Weineisen M; Schottelius M; Simecek J; Baum RP; Yildiz A; Beykan S; Kulkarni HR; Lassmann M; Klette I; Eiber M; Schwaiger M; Wester HJ
J Nucl Med; 2015 Aug; 56(8):1169-76. PubMed ID: 26089548
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-PSMA SPECT/CT Versus 68Ga-PSMA PET/CT in the Evaluation of Metastatic Prostate Cancer.
Fallahi B; Khademi N; Karamzade-Ziarati N; Fard-Esfahani A; Emami-Ardekani A; Farzanefar S; Eftekhari M; Beiki D
Clin Nucl Med; 2021 Feb; 46(2):e68-e74. PubMed ID: 33234922
[TBL] [Abstract][Full Text] [Related]
19. Chimeric cytokine receptor enhancing PSMA-CAR-T cell-mediated prostate cancer regression.
Weimin S; Abula A; Qianghong D; Wenguang W
Cancer Biol Ther; 2020 Jun; 21(6):570-580. PubMed ID: 32208880
[No Abstract] [Full Text] [Related]
20. 89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT.
Rosar F; Bartholomä M; Maus S; Privé BM; Khreish F; Franssen GM; Derks YHW; Nagarajah J; Ezziddin S
Clin Nucl Med; 2022 May; 47(5):435-436. PubMed ID: 35234197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
